Rivus Pharmaceuticals
Company

Rivus Pharmaceuticals

Biotechnology Research Charlottesville, Virginia, United States 27 employees
Employees
27
Contacts
4
Emails
4
Phones
2

Rivus Pharmaceuticals Overview

Headquarters
Charlottesville, Virginia, United States
Industry
Biotechnology Research
Employees
27
Founded
2019
Funding
57.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Rivus Pharmaceuticals

Rivus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company advancing novel medicines for obesity and the resulting chronic cardiometabolic diseases. Our team is developing a new class of oral investigational medicines called Controlled Metabolic Accelerators (CMAs). Our lead candidate HU6 (an ANT-activator) has demonstrated positive results in three Phase 2 clinical trials across MASH (metabolic dysfunction associated steatohepatitis), MASLD (metabolic dysfunction-associated steatotic liver disease), and HFpEF (heart failure with preserved ejection fraction). For more information, please visit www.rivuspharma.com.

Rivus Pharmaceuticals Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Rivus Pharmaceuticals Org Chart

Sample employees and titles
Name Title Contact
Mikael Herlevsen Ip Protection and Business Development
Email Phone
Robert J. Schott Md, Mph, Facc
Email
Christian Koch Head Bb Biotech @ Bellevue Asset
Email
Derek Dirocco Partner at Ra Capital Management, L.p.
Email Phone

Employees by Management Level

Individual contributor 3 profiles

Compare Similar Companies to Rivus Pharmaceuticals